Cargando…
High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?
BACKGROUND: Bladder recurrence after nephroureterectomy (NU) is common. However, there is no acceptable policy of adjuvant intravesical treatment after NU. OBJECTIVE: To assess the rate of bladder recurrence following NU and to identify the high-risk subgroups that may become candidates for adjuvant...
Autores principales: | Mekayten, Matan, Yutkin, Vladimir, Duvdevani, Mordechai, Pode, Dov, Hidas, Guy, Landau, Ezekiel H, Youssef, Fadi, Gofrit, Ofer N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973432/ https://www.ncbi.nlm.nih.gov/pubmed/29872646 http://dx.doi.org/10.2147/RRU.S164166 |
Ejemplares similares
-
The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer
por: Gofrit, Ofer N., et al.
Publicado: (2016) -
The growth rate of “clinically significant” renal cancer
por: Gofrit, Ofer N., et al.
Publicado: (2015) -
Cystoscopic-assisted partial cystectomy: description of technique and results
por: Gofrit, Ofer N, et al.
Publicado: (2014) -
The natural history of secondary muscle-invasive bladder cancer
por: Hidas, Guy, et al.
Publicado: (2013) -
Double mucosal flap for the reconstruction of transverse vaginal septum – A novel surgical approach using the vaginal septal tissue
por: Lorber, Amitay, et al.
Publicado: (2017)